MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Clinical correlation with the Genotype of Friedreich’s Ataxia (FRDA) patients in Indian population

    A.K Srivastava, I. Ahmad, P. Sharma, M. Seth, U. Shamim, I. Singh, R. Rajan, M.P Srivastava, F. Mohammad (New Delhi, India)

    Objective: To describe genotype-phenotype correlation in Indian FRDA patients. Background: Friedreich’s Ataxia(FRDA), an early onset  rare autosomal recessive ataxia is caused by bi-allelic loss of…
  • MDS Virtual Congress 2020

    Real-World Deutetrabenazine Dosing Patterns in Patients With Huntington’s Disease or Tardive Dyskinesia

    R. Ayyagari, A. Wilhelm, J. Alexander, N. Chaijale, V. Garcia-Horton, F. Devine, B. Carroll (Boston, MA, USA)

    Objective: To evaluate real-world treatment patterns and adherence to deutetrabenazine (DTBZ) in patients with Huntington’s disease (HD) or tardive dyskinesia (TD). Background: DTBZ is a…
  • MDS Virtual Congress 2020

    Cognitive function and depressive symptoms among older adults with serious difficulty walking in Americans

    Y. Zhang, Y. Qu, Q. Niu (Xi’an, China)

    Objective: The objective of this study was to ascertain level of cognitive function and its relationship with depression in American older adults with serious difficulty…
  • MDS Virtual Congress 2020

    Early-onset peak dose Levodopa induced dyskinesia in elderly Ethiopian Parkinson’s disease patient

    Y. Zewde (Addis Ababa, Ethiopia)

    Objective: The aim was to report an early onset peak dose dyskinesia in a 55 years old Parkinson's disease patient who was naive to treatment…
  • MDS Virtual Congress 2020

    The clinical features, treatments and genetic characteristics in Chinese children with dopa-responsive dystonia

    L. Dai, C. Ding, F. Fang (Beijing, China)

    Objective: To investigate the clinical manifestations, treatment and genetic characteristics of dopa-responsive dystonia (DRD). Background: Dopa-responsive dystonia (DRD) is resulted by variants of GCH1, TH and SPR. There…
  • MDS Virtual Congress 2020

    Prevalence of Spread of Dystonia and its effect on health-related quality of life in an Irish population with adult-onset isolated cervical dystonia.

    I. Ndukwe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: We aim to characterize clinical and demographic features and assess prevalence of spread of dystonia in relation to health-related quality of life in CD…
  • MDS Virtual Congress 2020

    Altered perceptual hand maps in focal hand dystonia

    T. Mainka, B. Ossmann, K. Zeuner, A. Baumann, T. Bäumer, A. Kühn, E. Azanon Gracia, S. Zittel, M. Longo, C. Ganos (Berlin, Germany)

    Objective: To assess implicit hand maps in patients with focal hand dystonia (FHD). Background: In FHD, changes in the perception of tactile stimuli are suggested…
  • MDS Virtual Congress 2020

    Time matters in brain health: how can health systems respond to the growing demand for genetic testing?

    A. Noyce, G. Giovannoni, P. Scheltens, D. Berg, L. Brown, K. Dierickx, G. Frisoni, J. Georges, J. Hardy, K. Heilbron (London, United Kingdom)

    Objective: The global burden of neurodegenerative disease is increasing and health systems are not yet equipped to manage large numbers of people who are at…
  • MDS Virtual Congress 2020

    Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes

    S. Hussain, A. Singh, H. Baxi, B. Taylor, J. Burgess, B. Antony (Delhi, India)

    Objective: This meta-analysis is aimed to explore the association between thiazolidinedione (TZD) use and Parkinson’s disease (PD) risk. Background: Recent epidemiological studies found protective effects of TZD class of drugs in…
  • MDS Virtual Congress 2020

    Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson´s disease in the United Kingdom

    L. Rutten-Jacobs, S. Roumpanis, Y. Liu, P. Coloma (Basel, Switzerland)

    Objective: To explore the association between prediagnostic symptoms and treatment initiation in people with Parkinson´s disease (PD) Background: Prediagnostic symptoms in people with PD may…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley